Michael R. Bielski Email and Phone Number
Michael R. Bielski work email
- Valid
Michael R. Bielski personal email
- Valid
Michael R. Bielski phone numbers
Michael R. Bielski, J.D., M.S. is a medical device, biotech and agtech entrepreneur. As an inventor and founder, Michael has brought technologies from conception, prototyping and patenting, through product development and manufacturing, and ultimately to the generation of licensing revenue, clinical use and sales. Michael is an expert across all areas of high-technology commercialization including out-licensing and start-up company formation. Michael works closely with clinician inventors out-licensing their medical technologies to industry. A structured licensing process, built around the in-licensing due diligence requirements of medical device companies, has resulted in multiple licenses for clinician inventors. This process includes validation of clinical problems and proposed solutions, professional development of marketing materials and highly-focused outreach to industry.Michael also works closely with technology companies to build innovation programs that identify, evaluate and in-license/acquire new technologies to support their product development efforts. These new technologies may also form the basis for revenue-generating out-licensing programs.Michael is an IP strategy expert, working closely with companies of all sizes to build systems that align their patents with the technical competitive advantages of their products. Along with being responsible for managing the filing of hundreds of patents, Michael is also an inventor on 5 medical device patents and applications.Michael founded DevTech Partners to advise inventors, founders and tech transfer offices on how to more effectively commercialize their technologies. Specialties: Patent Licensing, Start-Ups, Medical Devices, Clinician Invention and Licensing, Prototyping, Engineering, Product Development, Manufacturing, Regulatory, Intellectual Property Strategy, Patent Strategy, Venture Capital, Business Planning, Technology Transfer, Business Planning, Due Diligence
-
Founder And PresidentDevtech Partners Jan 2009 - PresentRonkonkoma, New York, UsDevTech Partners is a full-service technology commercialization firm with significant experience in product development, start-up company formation and management, and out-licensing campaigns. DevTech Partners works closely with physician inventors and research institutions to develop, test, patent and commercialize medical technologies via product manufacturing/sales and/or comprehensive out-licensing campaigns.Product Development: DevTech Partners directly manages the design, engineering, pre-clinical testing, patenting, regulatory, tooling, manufacturing, packaging, sterilization, marketing and sales of medical devices. The DevTech Partners team has successfully brought medical device technology from conception through clinical use and sales. The DevTech team often acts as the permanent or interim management team for start-ups formed to commercialize new technologies.Licensing: DevTech Partners works closely with inventors and research institutions to prepare for and directly manage comprehensive out-licensing campaigns. The DevTech Partners team has successfully developed licensing programs that have resulted in up-front fees, milestone payments, royalties, and collaboration agreements. -
Director Of InnovationDukal, Llc Nov 2019 - PresentRonkonkoma, New York, UsResponsible for identifying, evaluating, and licensing/acquiring new medical device technologies and products that align with Dukal’s strategic goals and innovation strategy. Focus on advanced wound care and surgical devices. Develop and implement IP strategy across all Dukal product lines. Technology Identification & Business Development: Responsible for identifying medical technologies and products that solve unmet clinical needs across Dukal’s product lines. Responsible for systematically identifying and managing the outreach and business development with research institutions, universities, and clinician inventors for new medical technologies for licensing or acquisition.Due Diligence: Responsible for managing the due diligence of new opportunities that include assessments from regulatory, finance, patent, legal, product development and manufacturing teams. Due diligence results presented to Dukal leadership for go/no-go decisions. Negotiation: Responsible for developing financial models that support the ROI/IRR for new opportunities and directly negotiating the terms of the license or acquisition including options, licenses and purchase agreements. Assets licensed or acquired include patents, patent applications, know-how, data, protocols, 510ks, and tooling.IP Strategy: Responsible for developing and implementing the intellectual property strategy for Dukal, including the invention extraction and documentation of patentable subject matter, know how and trade secrets. Responsible for management of outside patent counsel. -
Co-Founder, President And CeoCapseus Mar 2014 - PresentCapseus, Inc. (formerly OsteoMedix, Inc.) was founded in 2014 to develop and commercialize a Class II medical device (BDC-15) for the collection of autograft during spinal fusion procedures. Capseus developed the BDC-15 from early conception, design, engineering, patenting and testing through FDA registration, manufacturing, packaging, sterilization, clinical use and sales. -
Co-Founder And Managing PartnerHairpin Technologies Inc. Mar 2015 - Dec 2023Hairpin Technologies Inc. was founded in 2015 to expand the commercial distribution and research use of short hairpin RNA (shRNA), a versatile biomedical research and drug discovery tool invented at Cold Spring Harbor Laboratory (CSHL). As the exclusive licensing agent of CSHL, the mission of Hairpin Technologies is to negotiate and execute license agreements with manufacturers, distributors and end-users of the shRNA technology, which is protected by a robust portfolio of U.S. and international patents. In this capacity, Hairpin Technologies leads ongoing marketing, corporate outreach and out-licensing efforts to identify and engage potential licensees on behalf of CSHL. -
Co-Founder And Vp For Intellectual PropertyNewleaf Symbiotics, Inc. Jul 2011 - Dec 2014St. Louis, Missouri, UsResponsible for developing and implementing the intellectual property strategy for NewLeaf Symbiotics, Inc., a venture-backed agricultural biotechnology firm that has raised over $100M in financing and is commercializing a family of beneficial bacteria known as PPFMs (Pink Pigmented Facultative Methylotrophs). -
Assistant Director, Science & Technology CommercializationThe Center For Biotechnology Jul 2008 - Aug 2014Develop technology commercialization and risk-mitigation methodology for early-stage biomedical technology ventures. Advise existing early-stage life science companies on technology assessment, funding and partnership opportunities, IP strategy, licensing strategy, business planning and financial modeling. Manage teams that develop technology commercialization strategies for start-up life science companies. Assess early-stage technologies for licensing and commercialization potential. Member of the Bioscience Screening Committee for the Long Island Angel Network. Prepare early-stage life science companies to present to the Long Island Angel Network.
-
Adjunct FacultyTouro University Jacob D. Fuchsberg Law Center Apr 2010 - Apr 2012Central Islip, Ny, UsCourse Instructor for Selected Topics in Corporate Law: Garage to IPO. -
Adjunct FacultyStony Brook University College Of Business Jan 2008 - Jun 2010Stony Brook, Ny, UsDeliver technology commercialization courses to MBA students at SUNY Stony Brook. Manage student/client interactions for Industry Project (MBA 521). Invited Guest Lecturer, Technological Innovations Course, SUNY College of Business, 2008-2013. -
Senior AssociateIpcapital Group Sep 2005 - Jul 2008Williston, Vermont, UsConducted technical and IP due diligence for over $150 million in venture capital investments across multiple technologies including biomedical, security, consumer products and alternative energy. Developed and implemented IP strategies for Fortune 500 and start-up clients which included directed innovation, invention extraction and documentation processes. Identified and valued early stage technologies and IP for subsequent licensing/acquisition negotiations. Developed commercialization strategies and participated in patent licensing/acquisition negotiations. Conducted competitive patent analytics to identify IP strengths, weaknesses, opportunities and threats.
Michael R. Bielski Skills
Michael R. Bielski Education Details
-
Syracuse University College Of LawTechnology Transfer And Commercialization -
Syracuse UniversityNeuroscience -
Hofstra UniversityMolecular Biology -
Stony Brook UniversityBiology
Frequently Asked Questions about Michael R. Bielski
What company does Michael R. Bielski work for?
Michael R. Bielski works for Devtech Partners
What is Michael R. Bielski's role at the current company?
Michael R. Bielski's current role is Founder and President at DevTech Partners.
What is Michael R. Bielski's email address?
Michael R. Bielski's email address is mi****@****ail.com
What is Michael R. Bielski's direct phone number?
Michael R. Bielski's direct phone number is (631) 881*****
What schools did Michael R. Bielski attend?
Michael R. Bielski attended Syracuse University College Of Law, Syracuse University, Hofstra University, Stony Brook University.
What skills is Michael R. Bielski known for?
Michael R. Bielski has skills like Patents, Biotechnology, Intellectual Property, Commercialization, Start Ups, Licensing, Life Sciences, Lifesciences, Entrepreneurship, Venture Capital, Technology Transfer, Strategy.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial